Core Laboratories Stock Analysis

CLB
 Stock
  

USD 13.91  1.83  11.63%   

The big decline in price over the last few months for Core Laboratories could raise concerns from investors as the firm is trading at a share price of 13.91 on very low momentum in volume. The company executives failed to add value to investors and position the firm supply of money to exploit market volatility in August. However, diversifying your holdings with Core Laboratories NV or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.92. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Core Laboratories partners.
Continue to Trending Equities.
  
The Core Laboratories stock analysis report makes it easy to digest most publicly released information about Core Laboratories and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Core Laboratories Stock analysis module also helps to analyze the Core Laboratories price relationship with some important fundamental indicators such as market cap and management efficiency.

Core Laboratories Stock Analysis Notes

About 108.0% of the company shares are held by institutions such as insurance companies. The book value of Core Laboratories was currently reported as 3.07. The company has Price/Earnings To Growth (PEG) ratio of 1.36. Core Laboratories last dividend was issued on the 5th of August 2022. The entity had 2:1 split on the 9th of July 2010. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States. For more info on Core Laboratories NV please contact Lawrence Bruno at 31 20 420 3191 or go to https://www.corelab.com.

Core Laboratories Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Core Laboratories' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Core Laboratories NV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Core Laboratories generated a negative expected return over the last 90 days
Core Laboratories has high historical volatility and very poor performance
On 29th of August 2022 Core Laboratories paid $ 0.01 per share dividend to its current shareholders

Core Laboratories Upcoming and Recent Events

Earnings reports are used by Core Laboratories to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Core Laboratories previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report2nd of February 2022
Next Financial Report20th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End2nd of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Core Laboratories SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Core Laboratories prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Core Laboratories investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Core Laboratories specific information freely available to individual and institutional investors to make a timely investment decision.
27th of July 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
View
26th of July 2022
Financial Statements and Exhibits. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Entry into a Material Definitive Agreement
View
9th of June 2022
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
View
8th of June 2022
Other Events
View
19th of May 2022
Submission of Matters to a Vote of Security Holders
View
27th of April 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
View
16th of March 2022
Financial Statements and Exhibits. Regulation FD Disclosure
View
14th of February 2022
Unclassified Corporate Event
View

Core Laboratories Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Core Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Core Laboratories NV backward and forwards among themselves. Core Laboratories' institutional investor refers to the entity that pools money to purchase Core Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Ariel Investments LlcCommon Shares9.2 M181.9 M
Blackrock IncCommon Shares5.6 M111.6 M
Vanguard Group IncCommon Shares5.1 M101 M
Fred Alger Management LlcCommon SharesM79.7 M
Earnest Partners LlcCommon Shares3.3 M65.4 M
Boston Trust Walden CorpCommon SharesM39.5 M
Van Eck Associates CorpCommon Shares1.9 M38 M
Note, although Core Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Core Laboratories Market Capitalization

The company currently falls under 'Small-Cap' category with total capitalization of 643.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Core Laboratories's market, we take the total number of its shares issued and multiply it by Core Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Core Laboratories Profitablity

Core Laboratories' profitability indicators refer to fundamental financial ratios that showcase Core Laboratories' ability to generate income relative to its revenue or operating costs. If, let's say, Core Laboratories is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Core Laboratories' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Core Laboratories' profitability requires more research than a typical breakdown of Core Laboratories' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 1.82 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 10.64 %, which entails that for every 100 dollars of revenue, it generated 0.11 of operating income.

Management Efficiency

The entity has Return on Asset of 3.53 % which means that on every $100 spent on asset, it made $3.53 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.55 %, implying that it generated $5.55 on every 100 dollars invested. Core Laboratories management efficiency ratios could be used to measure how well core laboratories manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 24th of September, Core Laboratories shows the mean deviation of 3.09, and Risk Adjusted Performance of (0.12). Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Core Laboratories NV, which can be compared to its rivals. Please confirm Core Laboratories value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Core Laboratories is priced correctly, providing market reflects its regular price of 13.91 per share. Given that Core Laboratories has jensen alpha of (0.41), we suggest you to validate Core Laboratories NV's prevailing market performance to make sure the company can sustain itself at a future point.

Core Laboratories Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Kaufman Adaptive Moving Average allows the user to define Core Laboratories range across which they want the smoothing.
.

Core Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Tattoli over a month ago via Macroaxis 
Exercise or conversion by Mark Tattoli of 120 shares of Core Laboratories subject to Rule 16b-3
Murray Katherine over three months ago via Macroaxis 
Core Laboratories exotic insider transaction detected
Mark Tattoli over three months ago via Macroaxis 
Exercise or conversion by Mark Tattoli of 200 shares of Core Laboratories subject to Rule 16b-3
Kwaku Temeng over three months ago via Macroaxis 
Exercise or conversion by Kwaku Temeng of 4307 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over six months ago via Macroaxis 
Exercise or conversion by Tattoli Mark Damian of 110 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over six months ago via Macroaxis 
Acquisition by Tattoli Mark Damian of 17588 shares of Core Laboratories subject to Rule 16b-3
Christopher Hill over six months ago via Macroaxis 
Exercise or conversion by Christopher Hill of 23529 shares of Core Laboratories subject to Rule 16b-3
Gwendolyn Schreffler over six months ago via Macroaxis 
Exercise or conversion by Gwendolyn Schreffler of 4700 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over six months ago via Macroaxis 
Exercise or conversion by Tattoli Mark Damian of 160 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over six months ago via Macroaxis 
Acquisition by Tattoli Mark Damian of 6900 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over six months ago via Macroaxis 
Acquisition by Tattoli Mark Damian of 6900 shares of Core Laboratories subject to Rule 16b-3
Tattoli Mark Damian over a year ago via Macroaxis 
Core Laboratories exotic insider transaction detected

Core Laboratories Technical and Predictive Indicators

Core Laboratories Forecast Models

Core Laboratories time-series forecasting models is one of many Core Laboratories' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Core Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Core Laboratories Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Core Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Core Laboratories shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Core Laboratories. By using and applying Core Laboratories Stock analysis, traders can create a robust methodology for identifying Core Laboratories entry and exit points for their positions.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Current Core Laboratories Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Core Laboratories analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Core Laboratories analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
26.42Sell6Odds
Core Laboratories NV current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Core Laboratories analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Core Laboratories stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Core Laboratories, talking to its executives and customers, or listening to Core Laboratories conference calls.
Core Laboratories Analyst Advice Details

Core Laboratories Stock Analysis Indicators

Core Laboratories NV stock analysis indicators help investors evaluate how Core Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Core Laboratories shares will generate the highest return on investment. By understating and applying Core Laboratories stock analysis, traders can identify Core Laboratories position entry and exit signals to maximize returns.
Quick Ratio1.33
Trailing Annual Dividend Rate0.04
Fifty Two Week Low13.75
Revenue Growth1.80%
Payout Ratio21.05%
Average Daily Volume Last 10 Day457.43k
Shares Short Prior Month4.01M
Average Daily Volume In Three Month426.62k
Earnings Growth-11.80%
Shares Percent Shares Out11.17%
Earnings Quarterly Growth-12.30%
Gross Margins19.72%
Forward Price Earnings10.78
Short Percent Of Float18.48%
Float Shares46.03M
Fifty Two Week High35.83
Fifty Day Average16.98
Enterprise Value To Ebitda21.78
Two Hundred Day Average23.94
Enterprise Value To Revenue2.32
Trailing Annual Dividend Yield0.25%
Continue to Trending Equities. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.